Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs-Reference-Cited by-同舟云学术

Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs

Published:2024-03-26 Issue:2 Volume:23 Page:111-120
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Levine Rachel,Kahn Ryan M.,Perez Luiza,Brewer Jesse,Ratner Samantha,Li Xuan,Yeoshoua Effi,Frey Melissa K.

Funder

American Association of Obstetricians and Gynecologists Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10689-024-00373-4.pdf

Reference110 articles.

1. Whitaker KD et al Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention. JCO Precision Oncol, 2021(5):1387–1396

2. Offit K et al (2020) Cascading after Peridiagnostic Cancer Genetic Testing: an alternative to Population-based screening. J Clin Oncol 38(13):1398–1408

3. Domchek SM et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975

4. de Jong AE et al (2006) Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130(3):665–671

5. Center for Disease Control and Prevention Tier 1 Genomic Applications Toolkit for Public Health Departments. [cited 2019 12/9/2019]; Available from: https://www.cdc.gov/genomics/implementation/toolkit/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How hereditary cancer risk disclosure to relatives is handled in practice – Patient perspectives from a Swedish cancer genetics clinic;Patient Education and Counseling;2024-09